Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lopinavir/Ritonavir”

Showing 16 of 0 results

Post-approval studies (Phase 4)Study completedNCT00139178
What this trial is testing

Switching From Zidovudine to an NNRTI or Lopinavir/Ritonavir in Patients Treated With Zidovudine/ Lamivudine/Abacavir.

Who this might be right for
HIV Associated Lipodystrophy Syndrome.HIVHypercholesterolemia+1 more
Danish HIV Research Group 100
Post-approval studies (Phase 4)Study completedNCT00281606
What this trial is testing

Study to Assess the Tolerability of Once Daily Lopinavir/Ritonavir (LPV/r) Liquid Versus Capsules

Who this might be right for
HIV Infection
University of California, San Diego 65
Testing effectiveness (Phase 2)Study completedNCT00084058
What this trial is testing

Safety of Saquinavir and High Doses of Lopinavir/Ritonavir in Children With HIV

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 26
Large-scale testing (Phase 3)Study completedNCT00085943
What this trial is testing

KALETRA Or LEXIVA With Ritonavir Combined With EPIVIR And Abacavir In Naive Subjects Over 48 Weeks

Who this might be right for
HIV InfectionInfection, Human Immunodeficiency Virus
GlaxoSmithKline 866
Post-approval studies (Phase 4)Study completedNCT00619944
What this trial is testing

Drug Interaction Study Between Lumefantrine and Lopinavir/Ritonavir

Who this might be right for
HIV Infections
Makerere University 32
Post-approval studies (Phase 4)Study completedNCT00756730
What this trial is testing

Lopinavir/r or Fosamprenavir/r Switch to Atazanavir/r or Darunavir/r

Who this might be right for
HIV Infections
Community Research Initiative of New England 49
Not applicableStudy completedNCT04425382
What this trial is testing

Darunavir/Cobicistat vs. Lopinavir/Ritonavir in COVID-19 Pneumonia in Qatar

Who this might be right for
CoronavirusCOVIDPneumonia
Hamad Medical Corporation 400
Testing effectiveness (Phase 2)Study completedNCT00004582
What this trial is testing

ABT-378/Ritonavir and Efavirenz in HIV-Infected Patients Who Have Taken More Than One Protease Inhibitor in the Past

Who this might be right for
HIV Infections
ViRx
Large-scale testing (Phase 3)Study completedNCT00004583
What this trial is testing

A Phase III Study Comparing Two Different Anti-HIV Drug Combinations in HIV-Positive Patients Without Previous Anti-HIV Drug Therapy

Who this might be right for
HIV Infections
Abbott 660
Not applicableStudy completedNCT00200369
What this trial is testing

Characterization of the Adherence Threshold for HIV Suppression of a Kaletra-based Regimen

Who this might be right for
HIV Infection
Montefiore Medical Center 90
Large-scale testing (Phase 3)Study completedNCT00038519
What this trial is testing

Amprenavir/Ritonavir or Saquinavir/Ritonavir in HIV-Infected Subjects Following Failure With Kaletra as Their Second Protease Inhibitor

Who this might be right for
HIV Infections
Abbott 16
Post-approval studies (Phase 4)Study completedNCT00244712
What this trial is testing

Abacavir/Lamivudine Versus Emtricitabine/Tenofovir Both In Combination With Lopinavir/Ritonavir For The Treatment Of HIV

Who this might be right for
HIV Infection
GlaxoSmithKline 688
Early research (Phase 1)Study completedNCT00867152
What this trial is testing

GSK1349572 Drug Interaction With Etravirine and Either Darunavir/Ritonavir or Lopinavir/Ritonavir

Who this might be right for
Healthy Volunteer
ViiV Healthcare 17
Large-scale testing (Phase 3)Study completedNCT01172535
What this trial is testing

A Phase II/III Trial of Lopinavir/Ritonavir Dosed According to the WHO Pediatric Weight Band Dosing Guidelines

Who this might be right for
HIV
National Institute of Allergy and Infectious Diseases (NIAID) 97
Not applicableEnded earlyNCT04138199
What this trial is testing

Assess Effectiveness and Safety of Fixed Dose Combination of Lopinavir/Ritonavir (LPV/r) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected Patients After Switching From Kaletra in the Routine Clinical Settings of Russian Federation

Who this might be right for
HIV-1 Infection
AbbVie 239
Not applicableStudy completedNCT01662336
What this trial is testing

Real-life Effectiveness of the Kaletra Adherence Support Assistance (KASA) Program

Who this might be right for
Human Immunodeficiency Virus Infection
AbbVie (prior sponsor, Abbott) 173

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation